Index by author

April 01, 2002; Volume 69,Issue 4 suppl 1

Coxibs: Evolution of a Revolutionary Class: Evolving Concepts and Issues Surrounding COX-2 Inhibitors

  1. Bingham, Clifton O.

    1. Development and clinical application of COX-2–selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritis
      Clifton O. Bingham, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-5-SI-12;

  2. Cronstein, Bruce N.

    1. Cyclooxygenase-2–selective inhibitors: Translating pharmacology into clinical utility
      Bruce N. Cronstein, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-13-SI-19;

  3. Fendrick, A. Mark

    1. Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy
      A. Mark Fendrick, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-59-SI-64;

  4. Hochberg, Marc C.

    1. COX-2–selective inhibitors in the treatment of arthritis
      Thomas J. Schnitzer, MD, PhD and Marc C. Hochberg, MD, MPH
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-20-SI-30;
    2. Foreword
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-3-SI-4;

  5. Katz, Warren A.

    1. Cyclooxygenase-2–selective inhibitors in the management of acute and perioperative pain
      Warren A. Katz, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-65-SI-75;

  6. Konstam, Marvin A.

    1. Current perspective on the cardiovascular effects of coxibs
      Marvin A. Konstam, MD and Matthew R. Weir, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-47-SI-52;

  7. Lema, Mark J.

    1. Emerging options with coxib therapy
      Mark J. Lema, MD, PhD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-76-SI-84;

  8. Peura, David A.

    1. Gastrointestinal safety and tolerability of non-selective non-steroidal anti-inflammatory agents and cyclooxygenase-2–selective inhibitors
      David A. Peura, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-31-SI-39;

  9. Scheiman, James M.

    1. Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors
      James M. Scheiman, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-40-SI-46;

  10. Schnitzer, Thomas J.

    1. COX-2–selective inhibitors in the treatment of arthritis
      Thomas J. Schnitzer, MD, PhD and Marc C. Hochberg, MD, MPH
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-20-SI-30;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue